A blood test can be accurate and still need explanation. A hard training session may raise enzymes that also appear on a liver panel. More muscle can change how a creatinine result should be interpreted. Testosterone treatment can increase red cell production. Those are useful facts, but none gives an athlete permission to dismiss every flagged result.
GearCheck uses contextual rules to connect measured markers with information such as androgen exposure and training. The useful question is what that explanation changes: whether to verify the measurement, look for another marker, compare earlier results or bring a finding to a clinician. This guide shows how to read that process without giving the software more certainty than it has.
Start with three different things: measurement, explanation and decision
The measurement is what the laboratory reported, with a unit and reference interval. The explanation is a hypothesis about why it looks that way. The decision is what to do next. Keeping those separate prevents a common mistake: moving straight from “testosterone can cause this” to “nothing needs doing.”
For example, a raised hematocrit may be related to prescribed testosterone. That helps identify a possible cause. It does not establish an acceptable level for that person, exclude sleep apnea or remove the need to review treatment. A good report makes the reasoning visible instead of replacing an abnormal number with a reassuring adjective.
Reference intervals also deserve a fair reading. They are usually based on laboratory methods and selected reference populations, sometimes separated by age or sex. They are not simply ranges for sedentary people. Clinical decision thresholds answer different questions again. Our guide to reference intervals and athlete results explains why those distinctions matter.
Example one: a muscular lifter with a lower creatinine-based eGFR
Imagine a hypothetical lifter whose creatinine-based estimated glomerular filtration rate, or eGFR, is 74 mL/min/1.73 m². eGFR estimates how well the kidneys filter blood. Creatinine is one of the substances used in the calculation, and its concentration reflects production as well as clearance.
Large muscle mass, recent strenuous exercise, some supplements and a cooked meat meal can complicate the result. They make a misleadingly low creatinine estimate plausible. They do not prove it happened. The same athlete could also have high blood pressure, kidney disease or a new illness affecting kidney function.
The KDIGO kidney guideline supports using cystatin C and, where appropriate, a combined creatinine–cystatin C estimate when creatinine alone is less reliable. Urine albumin and evidence of persistence help assess kidney damage. An eGFR between 60 and 89 by itself does not establish chronic kidney disease, in an athlete or anyone else.
If cystatin C gives a more reassuring estimate, the disagreement is useful evidence. It still needs interpretation alongside urine findings, symptoms, blood pressure and the history. “Consider muscle-related distortion” is defensible. “Normal cystatin C proves healthy kidneys and no follow-up is needed” is too strong.
Example two: AST after a difficult training week
AST and ALT are enzymes that can rise when cells release their contents. They are often called liver enzymes, but skeletal muscle can contribute, especially to AST. This matters when a person has blood drawn after heavy lifting and receives an unexpected liver-panel flag.
In a small weightlifting study in healthy men, several blood markers, including AST, ALT and creatine kinase, increased after exercise and remained affected for days. That demonstrates a real source of confusion. It does not establish an exact recovery interval for every training session or every athlete.
Creatine kinase, usually shortened to CK, helps identify muscle injury. GGT, bilirubin and alkaline phosphatase can provide information about the liver and bile ducts. A high CK with normal GGT may support a muscle contribution, but normal GGT does not exclude liver disease. Exercise-related enzyme release and a drug-related liver problem can coexist.
For someone who feels well with a modest unexpected elevation, a clinician may arrange repeat testing after an appropriate recovery period. Someone with jaundice, dark urine, persistent vomiting or significant abdominal pain needs prompt assessment. Waiting for a planned rest-week blood draw would miss the point. The muscle-versus-liver explanation goes into this pattern in more detail.
Example three: low HDL during anabolic steroid exposure
Anabolic-androgenic steroids can lower HDL cholesterol and alter other lipids. An expected drug effect is still a drug effect worth reviewing. Calling it “normal for a cycle” describes how commonly it occurs, not whether the exposure is healthy.
ApoB can help assess the number of atherogenic particles, the particles involved in plaque formation. It adds information to LDL cholesterol and non-HDL cholesterol, particularly when those measures disagree. It cannot assess every cardiovascular consequence of anabolic steroid use, including high blood pressure, heart muscle changes or rhythm problems.
The prospective HAARLEM study of androgen exposure documented changes in blood pressure, lipids and hematocrit during use. These were observations in people using their own regimens, not a trial identifying safe cycles. A favorable ApoB result cannot turn that evidence into a guarantee about an individual's heart.
In GearCheck, supporting markers and exposure context can change the emphasis of a finding. Read the underlying values even when the summary sounds less concerning. Do not interpret a reduced scoring weight as evidence that lipid treatment is unnecessary or that continuing an exposure carries no additional risk.
Example four: a rising hematocrit on TRT
Hematocrit measures the proportion of blood occupied by red cells. Testosterone can increase red cell production, while dehydration can temporarily concentrate a sample. Smoking, altitude, sleep-disordered breathing and other conditions can also matter. The task is to assess the pattern and its cause, not choose one explanation because it is convenient.
The Endocrine Society testosterone guideline identifies hematocrit above 54% as a threshold for treatment interruption and evaluation in prescribed TRT. This is clinical guidance for hypogonadal men, not a universal risk boundary for every androgen user. It also does not mean lower results are automatically harmless.
Normal platelets do not rule out thrombosis or all causes of erythrocytosis. Regular training does not eliminate clot risk. You do not need a high platelet count, inactivity and high hematocrit together before a clinician takes an elevation seriously.
A contextual explanation should therefore lead to questions about the prescription, oxygenation, sleep apnea, blood pressure and prior results. It should not lead to an automatic blood-donation schedule. Repeated donation can deplete iron while the underlying cause continues.
What the software actually does with context
The current implementation contains named interpretation rules and a separate scoring model. Rules inspect recognized markers and the context available to the engine. Some change a marker's status or its contribution to the score; others add explanatory findings. Contextual results can retain a reduced scoring contribution. They are not all simply removed.
The distinction is important because a clinical explanation and a software weighting are different things. The software may have a rule for a familiar pattern without being able to verify the entire medical history. It cannot examine someone, confirm undisclosed substances or determine whether a symptom has been described accurately.
A rule also needs usable input. If a scan misreads a unit, a marker is missing or a user profile is incomplete, interpretation can change. Start by checking the original laboratory report against the extracted values. A polished explanation built on the wrong unit remains wrong.
Product behavior can evolve as the engine changes. These examples describe how to read contextual reasoning, not a promise that every report will show identical wording or an identical score. The Health Score guide explains how the headline summary relates to the findings underneath it.
How to challenge a reassuring interpretation
Ask what evidence supports the proposed explanation. If muscle mass is offered as the reason for a low eGFR, is there a supporting cystatin C estimate or only a profile saying “strength training”? If AST is attributed to lifting, does the timing fit, and have other liver findings been considered?
Then ask what evidence would change the conclusion. Persistent urine albumin, a falling combined eGFR, worsening bilirubin or symptoms may make an earlier explanation insufficient. A useful report should leave room for that change rather than making the original label feel permanent.
Finally, check whether the abnormality is stable, new or accelerating. Compare both similar treatment phases and an earlier untreated baseline where available. Comparing only one on-cycle result with another may show consistency while hiding how far both have moved from the person's usual health state.
Bring context to the consultation, not just a score
A short factual timeline is often more useful than a long theory. Include the sample date, symptoms, recent training, illness, prescribed treatment and any non-prescribed substances. Add home blood pressure readings when relevant and attach the original laboratory report. Be specific about changes instead of writing only “same as usual.”
You can ask the clinician which findings need confirmation, which need action now and which can be followed over time. Those are different tasks. A repeat sample may resolve a measurement problem, while persistent high blood pressure requires attention even when the chemistry panel is reassuring.
The value of context is better reasoning. It can reduce unnecessary alarm and identify where a common explanation is inadequate. GearCheck can help organize that reasoning, but the final assessment still depends on the person, the evidence and the limits of what has actually been measured.